Literature DB >> 34275803

Antihypertensive and safety studies of Cydonia oblonga M.

Muhammad Shafeeq Ur Rahman1, Muhammad Saleem2, - Alamgeer3, Mater Hussen Mahnashi4, Yahya Saeed Alqahtani4, Ali Omar Alqarni4, Bandar Ali Alyami4, Muhammad Naveed Mushtaq5, Sumera Qasim6.   

Abstract

Antihypertensive studies on aqueous-methanolic extract prepared from seeds of Cydonia oblonga M. were carried out. The test extract in 200, 400 and 600 mg/kg doses was investigated in normotensive, high cholesterol and glucose fed hypertensive rats through non-invasive blood pressure measuring technique. Acute and sub-chronic toxicity studies were conducted in mice and rats, respectively. The test extract significantly decreased dose dependently the systolic, diastolic and mean arterial pressures. The test extract in 600mg/kg dose produced maximum effect and prevented rise in blood pressure of high cholesterol diet and glucose fed rats as compare to control in 21 days studies. The extract was found safe up to 4g/kg dose in mice. In sub-chronic toxicity study, no significant alteration in blood chemistry of extract treated rats was observed except reduction in the low density cholesterol levels. It is concluded that Cydonia oblonga seeds extract possess antihypertensive effect which supports its use in folklore.

Entities:  

Mesh:

Substances:

Year:  2021        PMID: 34275803

Source DB:  PubMed          Journal:  Pak J Pharm Sci        ISSN: 1011-601X            Impact factor:   0.684


  2 in total

1.  Antihypertensive and Vasorelaxant Effects of Citrus aurantifolia Linn. Fruit: Proposed Mechanisms.

Authors:  Syed Nasir Abbas Bukhari; Sumera Saeed; Mulazim Hussain Asim; Hafiz Muhammad Irfan; Hasan Ejaz; Mervat A Elsherif; Kashaf Junaid
Journal:  Evid Based Complement Alternat Med       Date:  2022-05-20       Impact factor: 2.650

Review 2.  Cardiovascular Effects of Cydonia oblonga Miller (Quince).

Authors:  Atefeh Amerizadeh; Golnaz Vaseghi; Nazgol Esmaeilian; Sedigheh Asgary
Journal:  Evid Based Complement Alternat Med       Date:  2022-10-10       Impact factor: 2.650

  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.